Passa al contenuto
Merck

Abiotrophia defectiva bleb-associated endophthalmitis confirmed with 16s ribosomal RNA sequencing.

Journal of glaucoma (2013-08-24)
Ming-Han Hugo Lee, Mitchell Lawlor, Anne J Lee
ABSTRACT

One recognized complication of trabeculectomy with visually devastating potential is blebitis. We present a case of a 74-year-old woman with a culture and polymerase chain reaction-positive Abiotrophia defectiva bleb-associated endophthalmitis. Abiotrophia defectiva is a rare but possible cause of endophthalmitis secondary to blebitis and should be considered in culture-negative cases. Prompt identification, hence directed eradication, of the causative organism in such visually threatening cases may be facilitated by requesting polymerase chain reaction and 16S ribosomal RNA sequencing.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Vancomicina, ≥900 μg per mg (as vancomycin base)
Sigma-Aldrich
Vancomicina, ≥85% (Vancomycin B)
Sigma-Aldrich
Vancomicina, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Cephalothin sodium salt
Sigma-Aldrich
Vancomicina, meets USP testing specifications
Millipore
Vancomycin supplement, suitable for microbiology
USP
Ceftazidime pentahydrate, United States Pharmacopeia (USP) Reference Standard
Supelco
Atropine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Vancomycin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ceftazidime, European Pharmacopoeia (EP) Reference Standard
Atropine, European Pharmacopoeia (EP) Reference Standard
Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard
Ceftazidime for peak identification, European Pharmacopoeia (EP) Reference Standard
Cefalotin sodium, European Pharmacopoeia (EP) Reference Standard
Cefalotin for impurity B identification, European Pharmacopoeia (EP) Reference Standard